Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis
Clinical trial NCT06720025 · COMPLETED
Trial details
- NCT number
- NCT06720025
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2024-06-17
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.